Related Experiment Video
Updated: Sep 25, 2025
05:49
Protein Engineering by Yeast Surface Display
Published on: November 29, 2024
2.0K
Identification of Brain ECM Binding Variable Lymphocyte Receptors Using Yeast Surface Display.
Benjamin J Umlauf1,2, John S Kuo3,4, Eric V Shusta5
1Department of Neurosurgery, Dell Medical School, The University of Texas at Austin, Austin, TX, USA. benjamin.umlauf@austin.utexas.edu.
Methods in Molecular Biology (Clifton, N.J.)
|April 28, 2022
Summary
Researchers developed a novel method using variable lymphocyte receptor (VLR) yeast display to identify specific binders for brain extracellular matrix (ECM). This technique enables targeted discovery of tissue-specific ECM components.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Extracellular matrix (ECM) is a complex network of proteins and glycans essential for tissue structure and function.
- While ECM shares common components, unique tissue-specific variations exist, necessitating methods for their identification.
- Variable lymphocyte receptors (VLRs) offer a promising scaffold for developing targeted binding agents.
Purpose of the Study:
- To develop and validate a method for identifying tissue-selective binders to brain extracellular matrix (ECM).
- To utilize a variable lymphocyte receptor (VLR) yeast surface display library for this purpose.
- To establish a framework adaptable for other tissues and binding scaffolds.
Main Methods:
- Biopanning of a VLR yeast surface display library against brain ECM.
- Rapid ELISA-based screening of isolated clonal VLRs.
- Verification of VLR binding using immunostaining of murine brain sections.
Main Results:
- Successful identification of selective binders to brain ECM using the described VLR yeast display approach.
- Demonstration of VLRs binding specifically to ECM components within brain tissue.
- Validation of the workflow for isolating and verifying tissue-specific ECM binders.
Conclusions:
- The VLR yeast surface display technique combined with biopanning and ELISA provides an effective framework for discovering tissue-selective ECM binders.
- This method can be readily adapted for identifying binders to ECM from other tissues.
- The approach holds potential for applications in diagnostics and therapeutics targeting specific ECM components.
